Eyenovia (Nasdaq:EYEN) announced that it began manufacturing batches of its Mydcombi product for its next-generation delivery ...

The combination of cyclopentolate hydrochloride 0.2% and phenylephrine hydrochloride 1% (Cyclomydril ®) is desirable for mydriasis prior to examining premature infants because it delivers lower ...

In a unanimous vote, the panel concluded that oral formulations of phenylephrine – used in big-selling brands like Sudafed, Benadryl, and some Advil and Tylenol products, from companies ...

The Gen-2 Optejet is designed for an optimized user experience while ensuring extended patent protection for products using the platform through 2041NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- (NASDAQ ...

A woman in her mid-60s who is a high hypermetrope presented with bilateral eye pain and headache approximately 1 hour after taking a single dose of a widely available decongestant containing ...

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company with two FDA-approved products and a late-stage asset in development for the ...

About Eyenovia, Inc. Eyenovia, Inc. is an ophthalmic technology company commercializing Mydcombi™ (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for mydriasis ...

The HCL journey has been relentless, gratifying and marked with a series of achievements. Our unified efforts have catapulted the company from a garage start-up to a conglomerate whose businesses span ...

Below is the complete list of 48 drugs declared "not of standard quality" in the CDSCO's August 2024 report. You can check ...

The central drug regulator released two lists – one was a list of 48 drugs that failed the quality tests and another had ...

The Central Drugs Standard Control Organization (CDSCO) has alerted a notification issuing 48 identified pharmaceutical which ...